Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more
PEN is expected to report earnings to rise 37.50% to $1.21 per share on November 04
Q3'26
Est.
$1.21
Q2'26
Missed
by $0.28
Q1'26
Missed
by $0.25
Q4'25
Beat
by $0.08
Q3'25
Beat
by $0.04
The last earnings report on July 30 showed earnings per share of 87 cents, missing the estimate of $1.16. With 239.68K shares outstanding, the current market capitalization sits at 12.57B.